Bioequivalence study of IMP4297 capsules of different specifications in healthy subjects
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Senaparib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Ying Shi Jun Pai Pharmaceutical
- 21 Jan 2025 New trial record